Objective-Adrenomyeloneuropathy (AMN) is an X linked metabolic disorder presenting with progressive spastic paraparesis in the third to fifth decade of life. Although peripheral neuropathy is also present in most patients, prominent pyramidal signs may make its clinical recognition difficult. Although peripheral neuropathy is present in most patients with AMN, prominent pyramidal signs often make its clinical detection difficult. Failure to recognise the associated neuropathy may lead to the misdiagnoses of multiple sclerosis or "idiopathic paraparesis".' 78
Although peripheral neuropathy is also present in most patients, prominent pyramidal signs may make its clinical recognition difficult. The objective was to characterise the peripheral neuropathy in patients with AMN by nerve conduction studies. Methods-Nerve conduction studies were performed in 99 men known to have AMN and in 38 heterozygous women, all of whom had neurological disabilities. Results-Of the 13 variables obtained, at least one was abnormal in 82% of patients. The abnormalities were more common in men than in women (87% v 67%); in legs than in arms (77% v 38%); in motor than in sensory conduction (80% v 39%); and in latency (distal and F wave) and velocity compared with amplitude (80% v 29%). Twenty six patients had at least one nerve variable value in the demyelinating range. Four variables (sural velocity, peroneal amplitude, peroneal velocity, and peroneal F wave) were correlated with the expanded disability status scale; five variables (peroneal velocity, tibial H reflex, median distal latency, median conduction velocity, and median F wave latency) were correlated with serum very long chain fatty acids (VLCFAs); and two variables (sural amplitude and peroneal distal latency) were more likely to be abnormal in patients with normal adrenal function than in patients with Addison's disease.
Conclusions-Nerve conduction studies in patients with AMN are often abnormal and suggest a mixture of axonal loss and multifocal demyelination. Their In each patient nerve conduction of the right sural and median sensory nerves, right peroneal and median motor nerves including F wave latencies, and right tibial H reflex latency were recorded with techniques standard in our laboratory. All studies were performed with an infrared temperature control system to maintain surface limb temperature (lateral border of the right foot and tip of digit 3) at 34°C. Thirteen variables of nerve conduction were measured in each patient as follows: sural and median sensory nerve action potential (SNAP) amplitudes and velocities; common peroneal and median distal latencies, conduction velocities, compound muscle action potential (CMAP) amplitudes, F wave latencies, and H reflex latency. For sensory nerves, SNAP amplitude was measured from peak to peak and velocity calculated by dividing the distance by onset latency; for motor nerves, CMAP amplitude was measured baseline to peak, distal latency and conduction velocity were calculated in the standard fashion, and F wave latency was obtained as the shortest of 10 trials; the onset latency was measured for the H reflex. Abnormal values for each variable were based on the standardised upper and lower limits of normal for our laboratory ( Table 2 gives the mean (SD) of the 13 variables for the men and women. Significant differences between men and women were found in the sural amplitude, peroneal motor distal latency, conduction velocity, and median motor distal latency. At least one of the 13 variables obtained was abnormal in 82% of patients. Eighty one per cent of the patients had an abnormality noted in at least one nerve; 47% had two or more nerves that were abnormal; 31% had abnormalities in three nerves; and 7% showed abnormality in all four tested nerves. Based on the abnormalities in at least one nerve, the abnormalities were more often seen in men than women (87% v 67%); in lower limb nerves than in upper limb nerves (77% v 38%); and in motor nerves than in sensory nerves (80% v 39%) (fig 1) . In both men and women, common peroneal F wave latency was most often abnormal (64% of patients), followed by peroneal conduction velocity (53% of patients) and the H reflex latency (44% of patients). Variables related to latencies (distal and F wave) and conduction velocity were more often abnormal than the amplitudes (80% v 29%) (figs 2 and 3).
At least one value in the demyelinating range was found in 26% of patients; 9% had two or more; 3% had three or more, and 1% had four or more. Demyelinating values were detected more often in men (31 %) than in women (12%) and in the nerves of the lower limbs (19%) than in the nerves of the upper limbs (9%), where noted changes could be easily attributable to focal nerve entrapment (figs 2 and 3).
Demyelinating changes did not appear uniformly distributed over the length of a motor fibre. For present study attempts to answer these questions.
FREQUENCY
Nerve conduction studies confirmed the presence of neuropathy in most of the patients with AMN. Men with AMN were more likely to show abnormal findings than heterozygous women; motor nerves to show more frequent abnormalities than sensory; and lower limb nerves to show more frequent changes than upper limb nerves.
CHARACTERISATION
Even though the absolute value of changes in the nerve conduction study variables were in the axonal range, the pattern of physiological abnormalities noted was not typical of a distal axonopathy. For example, measures related to functioning myelin (distal latency, F wave latency, and conduction velocity) were more commonly affected than amplitude, a measure generally associated with the number of functional axons; motor nerve abnormalities were more frequent than sensory nerve abnormalities; and the findings appeared non-uniform over adjacent nerve segments (table 3) . However, the distribution of affected nerves was length dependent, as typically seen in an axonopathy, and individual latency values were rarely in the range associated with primary demyelination. Overall, this mixed pattern suggesting multifocal demyelination and axonal loss is well described in "metabolic neuropathies" such as diabetes.22
Other studies also support the notion that the peripheral neuropathy associated with AMN has both axonal and demyelinating features. Microscopically, sural nerves have been reported to show a mixture of axon and myelin loss. Some report frequent formation of small "onion bulbs" and thinly myelinated fibres suggestive of remyelination.' 1323 Also, teased fibre studies have confirmed the existence of chronic demyelination-remyelination. 3 Muscle biopsy from peroneal muscles shows changes of denervation and reinnervation secondary to axonal loss. ' Although the association between AMN and VLCFA accumulation is in no doubt, it remains uncertain whether fatty acid abnormality is the direct cause of the neuropathology, whether secondary pathogenetic factors are required, or whether VLCFA excess is an epiphenomenon. There is evidence that accumulation of VLCFA has a deleterious effect on membrane structure and function,25 27 but the great variability of the ALD phenotypes even within families, and the lack of correlation of VLCFA concentrations with neurological disability, suggest that other factors beyond accumulation of VLCFA are involved in pathogenesis. One such factor may be immune mediated damage. The rapid neurological progression in the childhood cerebral form is associated with demyelination and an intense perivascular inflammatory response. Recent studies suggest that cytokines such as tumour necrosis factor-a are involved in this process.28
It may be that the abnormal accumulation of lipids in AMN acts, in some patients, as an antigen initiating immunological damage.3 As this immune mediated process might be expected to be non-uniform, it offers a possible explanation for the multifocality of the changes seen here. A review of previous nerve conduction studies in AMN showed that they were consistent with our findings (table 4), although detailed descriptions were limited and patient numbers were small. A recent publication'8 is interesting in this regard. Similar to our study, the abnormal findings were more prominent in lower limb nerves than in upper limbs and in latency and conduction velocity values than in amplitude values. And even though 26% of patients had demyelinating findings in one or more nerves, the conclusion of the paper was that neuropathy in patients with AMN is due to primary axonal demyelination. We think that this supports the concept that the neuropathy has mixed features of axonal degeneration and multifocal demyelination.
In conclusion, we report that results of nerve conduction studies are often abnormal in men and heterozygous women with AMN, are helpful in diagnosis and prognosis, and may be useful in future therapeutic trials. The findings have features of both a multifocal demyelinating process and an axonopathy. Common peroneal motor nerve conduction studies are the most useful for screening, for longitudinal follow up, and to assess the results of a therapeutic intervention. 
